Description

4(3H)-Quinazolinone,6,7-Dimethoxy-2-Methyl-3-[[(6,7,8,9-Tetrahydro-2-Hydroxydibenzofuran-1-Yl)Methylene]Amino]-(9Ci) CAS NO 587009-06-1 is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure. This compound is of significant value in medicinal chemistry research and development, particularly for its potential role as a key building block in the synthesis of novel bioactive molecules. It is primarily sought after by research institutions and pharmaceutical companies engaged in the discovery of new therapeutic agents, especially within oncology and central nervous system (CNS) drug discovery pipelines.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the multi-step synthesis of potential drug candidates, particularly those targeting specific enzyme pathways.
• Medicinal Chemistry Research: Used as a scaffold or building block for constructing compound libraries in high-throughput screening (HTS) campaigns to identify new lead structures.
• Oncology Drug Discovery: Investigated for the development of novel kinase inhibitors or other targeted therapies due to its quinazolinone core, a privileged structure in cancer research.
• CNS-Active Compound Synthesis: Applied in the research of potential neuroprotective agents, antidepressants, or antipsychotics, leveraging its fused heterocyclic system.
• Chemical Biology Probes: Utilized to create tool compounds for studying biological processes and target validation within cellular systems.
• Contract Research & Development (CRO): Supplied to service organizations supporting pharmaceutical clients with custom synthesis and process development.

Basic Information

Product Name	4(3H)-Quinazolinone,6,7-Dimethoxy-2-Methyl-3-[[(6,7,8,9-Tetrahydro-2-Hydroxydibenzofuran-1-Yl)Methylene]Amino]-(9Ci)
CAS No.	587009-06-1
Molecular Formula	C26H25N3O5
Molecular Weight	459.50 g/mol
Synonyms	6,7-Dimethoxy-2-methyl-3-[(6,7,8,9-tetrahydro-2-hydroxydibenzofuran-1-yl)methyleneamino]quinazolin-4(3H)-one; 3-[(6,7,8,9-Tetrahydro-2-hydroxydibenzofuran-1-yl)methyleneamino]-6,7-dimethoxy-2-methyl-4(3H)-quinazolinone; 6,7-Dimethoxy-2-methyl-3-[[(6,7,8,9-tetrahydro-2-hydroxy-1-dibenzofuranyl)methylene]amino]-4(3H)-quinazolinone; (9CI) Quinazolinone derivative 587009-06-1.
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Every batch is subjected to rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. A comprehensive Certificate of Analysis (COA) detailing all specifications and test results is provided with each shipment. We support our clients' regulatory needs with full traceability and documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound may be light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (HPLC)	Conforms to reference standard
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.